A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

Abroad (travel likely)Recruiting

Conditions

Atopic Dermatitis · Eczema

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • CHU Amiens-Picardie - Site Nord, Amiens, Somme, France

  • CHU Besancon - Hopital Jean Minjoz, Besançon, France

  • Polyclinique Reims Bezannes, Bezannes, France

  • Chu Bordeaux Hopital Saint Andre, Bordeaux, France

  • CHU Brest Hopital Morvan, Brest, France

  • CHU de Caen, Caen, France

  • Ch de Calais, Calais, France

  • Ch William Morey, Chalon-sur-Saône, France

  • CHU Clermont Ferrand - Hopital Gabriel Montpied, Clermont-Ferrand, France

  • Chu Estaing, Clermont-Ferrand, France

  • Hopital Henri Mondor, Créteil, France

  • Chu Dijon, Dijon, France

  • Hopital Franco Britannique, Levallois-Perret, France

  • Hopital Claude Huriez, Lille, France

  • CH de Martigues, Martigues, France

  • CHU Montpellier, Montpellier, France

  • Hopital Emile Muller, Mulhouse, France

  • Hopital Hotel Dieu, Nantes, France

  • Hopital Cochin, Paris, France

  • Hopital Tenon, Paris, France

  • Hopital Saint Louis (APHP) - Service Hematologic Senior, Paris, France

  • CHU Lyon Sud, Pierre-Bénite, France

  • Hopital Pontchaillou, Rennes, France

  • Ch de Romans Sur Isere, Romans-sur-Isère, France

  • Hopital Charles Nicolle, Rouen, France

  • Chi Poissy Saint Germain En Laye, Saint-Germain-en-Laye, France

  • Hopital Bégin, Saint-Mandé, France

  • Hopital Larrey, Toulouse, France

  • Ch de Valenciennes, Valenciennes, France

  • CHU Nancy, Vandœuvre-lès-Nancy, France

Study leads
  • Pfizer CT.gov Call Center

    Study Director

    Pfizer